Workup for a Fetus at 5th Percentile at 20 Weeks
A fetus measuring at the 5th percentile at 20 weeks gestation does NOT meet the formal definition of fetal growth restriction (FGR) and therefore amniocentesis should NOT be routinely offered based on size alone, unless additional concerning features are present. However, this fetus warrants close surveillance and a detailed anatomic survey to determine if diagnostic testing is indicated.
Understanding the Clinical Context
The 5th percentile measurement falls below the 10th percentile threshold that defines FGR, but the critical distinction here is whether this represents true pathologic growth restriction or constitutional smallness 1. At 20 weeks gestation, this is considered early-onset (diagnosed <32 weeks), which carries higher risk for chromosomal and structural abnormalities compared to late-onset FGR.
Initial Workup Algorithm
Step 1: Verify Gestational Age
- Confirm dating accuracy using first-trimester crown-rump length measurement between 11-14 weeks 2
- Incorrect dating is a common pitfall that can falsely suggest growth restriction
Step 2: Perform Detailed Anatomic Survey
Immediately obtain a detailed obstetrical ultrasound examination (CPT 76811) to evaluate for:
- Structural malformations (cardiac, renal, CNS, skeletal)
- Polyhydramnios
- Head circumference, abdominal circumference, and femur length measurements
- Any organ system abnormalities 1
Step 3: Umbilical Artery Doppler Assessment
- Initiate serial umbilical artery Doppler studies to assess placental function 1
- This becomes the cornerstone of ongoing surveillance once size discrepancy is confirmed
When to Offer Amniocentesis
Amniocentesis with chromosomal microarray analysis (CMA) should be offered in the following scenarios:
Definite Indications:
- If ANY structural malformation is detected on detailed ultrasound, regardless of severity 1
- If polyhydramnios is present alongside the small size 1
- If the fetus is truly isolated FGR at <32 weeks (which this case qualifies for gestational age) AND remains unexplained after anatomic survey 1
The Evidence Supporting This Approach:
The 2020 SMFM guidelines provide Grade 1B and 1C recommendations that are unequivocal: offer diagnostic testing with CMA when early-onset FGR (<32 weeks) is accompanied by malformations or when isolated and unexplained 1. The diagnostic yield for isolated small size is approximately 6.3% for pathological findings, with CGH array detecting abnormalities that conventional karyotyping would miss 3.
Specific Amniocentesis Considerations at 20 Weeks
If amniocentesis is indicated:
- Timing: Perform after 15+0 weeks (this case at 20 weeks is appropriate) 4
- Testing panel: Order chromosomal microarray analysis (not just karyotype) 1
- Add CMV PCR if amniocentesis is performed for unexplained FGR 1
- Do NOT routinely screen for toxoplasmosis, rubella, or herpes unless other risk factors present 1
- Procedure-related loss risk: Approximately 1.1% at this gestational age, with slightly higher rates earlier in second trimester 5
Critical Pitfalls to Avoid
Don't automatically offer amniocentesis for size alone: The 5th percentile without other findings may represent constitutional smallness. The detailed anatomic survey determines next steps.
Don't miss the window for CMA: If you're going to do amniocentesis, order chromosomal microarray, not just karyotype—it detects clinically significant copy number variants in 5.1% of cases that karyotype misses 3.
Don't delay the detailed ultrasound: This is the pivotal decision point that determines whether invasive testing is warranted.
Don't forget to counsel about uncertain findings: CMA can detect variants of unknown significance that cause parental anxiety 3.
Ongoing Surveillance Plan
Regardless of whether amniocentesis is performed:
- Serial growth ultrasounds every 2-3 weeks 2
- Serial umbilical artery Doppler assessments 1
- If Doppler remains normal and growth trajectory is maintained, weekly cardiotocography after viability 1
The Bottom Line
For a fetus at the 5th percentile at 20 weeks: perform a detailed anatomic ultrasound immediately. If this reveals ANY structural abnormality or polyhydramnios, offer amniocentesis with CMA. If the anatomy is completely normal and this represents isolated early-onset small size, amniocentesis with CMA should still be offered given the <32 week diagnosis, though the yield will be lower (approximately 6%) 1, 3. The patient's values regarding the information gained versus the 1% procedure-related loss risk should guide the final decision 4, 5.